Quintiles Acquisition To Strengthen Its Tissue-Based Testing In Oncologic Development
This article was originally published in The Pink Sheet Daily
Executive Summary
Newly acquired Targeted Molecular Diagnostics will become Quintiles’ oncology biomarker R&D center.